Tongji Hospital: Ovarian Neoplasms trials
The registry lists 13 Ovarian Neoplasms studies with Tongji Hospital as lead sponsor. 8 are open to participants now and 0 have results posted.
Phase 1 2Phase 2 3Phase 3 2No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Prospective Sample Collection Study for a Blood-Based cfDNA Methylation Assay for Ovarian Cancer DetectionNot yet recruitingNCT07593833
- Impact of Dietary Patterns on Prognosis of Ovarian Cancer Patients During PARPi MaintenanceNot yet recruitingNCT07269574
- SHR - A1811 Injection in the Treatment of Platinum-sensitive Recurrent Ovarian CancerNot yet recruitingNCT06990516Phase 1/2
- SHR - A1811 Versus Chemotherapy for Platinum-resistant Recurrent Epithelial Ovarian CancerNot yet recruitingNCT06990503Phase 3
- Fluzoparib+Bevacizumab/Dietary Intervention vs Fluzoparib Monotherapy as First-line Maintenance in HRD+/- Advanced Ovarian CancerRecruitingNCT06954584Phase 3
- The Efficacy and Safety of FRD001 in Ultrasound Contrast Imaging for Malignant Ovarian Masses in WomenRecruitingNCT06556342Not applicable
- Safety and Efficacy of KM1 in Subjects With Recurrent or Refractory Ovarian CancerRecruitingNCT05684731Phase 1
- A Non-interventional Registry Study of Fluzoparib in the Treatment of Ovarian CancerRecruitingNCT05206890
- A Biomarker Exploration Study of Precision Treatment in Ovarian CancerActive, not recruitingNCT06483425
- Systematic Lymphadenectomy During Interval Debulking Surgery in Advanced Epithelial Ovarian CancerCompletedNCT06385912
- Biomarker-driven Targeted Therapy in Patients With Recurrent Platinum-resistant Epithelial Ovarian CancerCompletedNCT05044871Phase 2
- Niraparib for the Neoadjuvant Treatment of Unresectable Ovarian CancerActive, not recruitingNCT04507841Phase 2
- Detection of Ovarian Cancer Using an Artificial Intelligence Enabled Transvaginal Ultrasound Imaging AlgorithmStatus unknownNCT04214782Not applicable